Friday 1 November 2013

Cempra’s Taksta secures FDA orphan drug status for prosthetic joint infections treatment « New Drug Approvals

Cempra’s Taksta secures FDA orphan drug status for prosthetic joint infections treatment « New Drug Approvals:

'via Blog this'

No comments:

Post a Comment